Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Forman

Showing results (291-300 of 503) with videos related to

Pageof 51
Sort By:
European Journal of Haematology|March 15, 2021
Cytokine gene polymorphisms are associated with response to blinatumomab in B-cell acute lymphoblastic leukemiaNikeshan Jeyakumar, Ibrahim Aldoss, Dongyun Yang, et al.
Leukemia & Lymphoma|March 14, 2013
Detection and preliminary characterization of CD8+T lymphocytes specific for Wilms' tumor antigen in patients with non-Hodgkin lymphomaAnna Israyelyan, Corinna La Rosa, Weimin Tsai, et al.
Journal for Immunotherapy of Cancer|June 23, 2022
PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophagesYukiko Yamaguchi, Jackson Gibson, Kevin Ou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 23, 2020
Developing and Monitoring a Standard-of-Care Chimeric Antigen Receptor (CAR) T Cell Clinical Quality and Regulatory ProgramSylvia O Dulan, Kathie L Viers, Jamie R Wagner, et al.
Cancer|October 26, 2023
Health care utilization by long-term survivors of blood or marrow transplantation-A Bone Marrow Transplant Survivor Study reportMarian M Oliver, Qingrui Meng, Lindsey Hageman, et al.
Transplantation and Cellular Therapy|November 29, 2021
Cytokine Release Syndrome Following Peripheral Blood Stem Cell Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation CyclophosphamideSalman Otoukesh, Hany Elmariah, Dongyun Yang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 17, 2020
Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplant with Fludarabine and Melphalan Conditioning and Tacrolimus/Sirolimus as Graft-versus-Host Disease Prophylaxis in Patients with Acute Lymphoblastic LeukemiaMatthew Mei, Ni-Chun Tsai, Sally Mokhtari, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2017
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against GlioblastomaChristine E Brown, Brenda Aguilar, Renate Starr, et al.
Haematologica|March 17, 2018
Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemiaIbrahim Aldoss, Dongyun Yang, Ahmed Aribi, et al.
American Journal of Hematology|February 8, 2022
High prevalence and inferior long-term outcomes for TP53 mutations in therapy-related acute lymphoblastic leukemiaHoda Pourhassan, Dongyun Yang, Michelle Afkhami, et al.
Pageof 51

Showing results (291-300 of 503) with videos related to

Sort By:
Pageof 51
European Journal of Haematology|March 15, 2021
Cytokine gene polymorphisms are associated with response to blinatumomab in B-cell acute lymphoblastic leukemiaNikeshan Jeyakumar, Ibrahim Aldoss, Dongyun Yang, et al.
Leukemia & Lymphoma|March 14, 2013
Detection and preliminary characterization of CD8+T lymphocytes specific for Wilms' tumor antigen in patients with non-Hodgkin lymphomaAnna Israyelyan, Corinna La Rosa, Weimin Tsai, et al.
Journal for Immunotherapy of Cancer|June 23, 2022
PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophagesYukiko Yamaguchi, Jackson Gibson, Kevin Ou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 23, 2020
Developing and Monitoring a Standard-of-Care Chimeric Antigen Receptor (CAR) T Cell Clinical Quality and Regulatory ProgramSylvia O Dulan, Kathie L Viers, Jamie R Wagner, et al.
Cancer|October 26, 2023
Health care utilization by long-term survivors of blood or marrow transplantation-A Bone Marrow Transplant Survivor Study reportMarian M Oliver, Qingrui Meng, Lindsey Hageman, et al.
Transplantation and Cellular Therapy|November 29, 2021
Cytokine Release Syndrome Following Peripheral Blood Stem Cell Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation CyclophosphamideSalman Otoukesh, Hany Elmariah, Dongyun Yang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 17, 2020
Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplant with Fludarabine and Melphalan Conditioning and Tacrolimus/Sirolimus as Graft-versus-Host Disease Prophylaxis in Patients with Acute Lymphoblastic LeukemiaMatthew Mei, Ni-Chun Tsai, Sally Mokhtari, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2017
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against GlioblastomaChristine E Brown, Brenda Aguilar, Renate Starr, et al.
Haematologica|March 17, 2018
Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemiaIbrahim Aldoss, Dongyun Yang, Ahmed Aribi, et al.
American Journal of Hematology|February 8, 2022
High prevalence and inferior long-term outcomes for TP53 mutations in therapy-related acute lymphoblastic leukemiaHoda Pourhassan, Dongyun Yang, Michelle Afkhami, et al.
Pageof 51